Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

 

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient
D

ASH 2019 Update on Promising New Agents in R/R Multiple Myeloma: Iberdomide, TAK573, Tasquinimod & Choosing Therapies with Limited Data

By Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient FEATURING Dan T. Vogl
By Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient FEATURING Dan T. Vogl
19 views
February 24, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Controversies and Update for Patient Care in Multiple Myeloma
17:09

Should We Treat High-Risk Smoldering Myeloma, Trials with Daratumuma…

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

A. Garfall

559 views
11:50

Transplant and Maintenance in Frontline Multiple Myeloma: High-dose …

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

A. Garfall

36 views
21:42

ASH 2019 Update on New Therapies for Relapsed Myeloma: Daratumumab, …

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

D. Vogl

38 views
09:09

ASH 2019 Update on Promising New Agents in R/R Multiple Myeloma: Ibe…

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

D. Vogl

19 views
26:41

BCMA - Based Immunotherapy for Myeloma: Belantamab Mafodotin, CAR-T …

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

A. Cohen

288 views
21:58

Treatment of 57 y/o Women with Myeloma R-ISS Stage 1, Anemia and Lyt…

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

A. Cohen, D. Vogl, A. Garfall

27 views